Found 6 matching trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
PHASE3The purpose of this study is to evaluate the efficacy, safety, and tolerabi...
Location
Teva Investigational Site 14742
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Chronic Migraine
PHASE2To evaluate the efficacy and safety of subcutaneous (SC) administration of ...
Location
Saitama Medical University Hospital
A Study to Explore the Long-Term Safety and Efficacy of Fremanezumab (TEV-48125) for the Prevention of Cluster Headache
PHASE3This is a 68-week study to evaluate the long-term safety and efficacy of fr...
Location
Teva Investigational Site 13834
A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period on Efficacy and Safety of Fremanezumab in Chinese Adults With Migraine
PHASE3Primary Objective:
To demonstrate the efficacy of fremanezumab administere...
Location
Teva Investigational Site 88028
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Episodic Migraine
PHASE2To evaluate the efficacy and safety of subcutaneous (SC) administration of ...
Location
Saitama Medical University Hospital
Efficacy and Safety of Subcutaneous Administration of Fremanezumab (TEV-48125) for the Preventive Treatment of Migraine
PHASE3A study to evaluate the long-term safety, tolerability, and efficacy of sub...
Location
Teva Investigational Site 13628